Previous research on PELI2 focused on inflammatory responses (Humphries et al. 2018), and and some studies have also linked PELI2 to leukaemia (Modarres et al. 2021), gastric cancer (Zhang et al. 2019), and multiple myeloma (Masuda et al. 2022). The gene discussed is PELI2; the disease is plasma cell myeloma.